174 related articles for article (PubMed ID: 21531994)
1. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.
Weghofer A; Dietrich W; Barad DH; Gleicher N
Hum Reprod; 2011 Jul; 26(7):1905-9. PubMed ID: 21531994
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.
Gleicher N; Weghofer A; Barad DH
Fertil Steril; 2010 Dec; 94(7):2824-7. PubMed ID: 20538269
[TBL] [Abstract][Full Text] [Related]
3. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.
Nelson SM; Yates RW; Fleming R
Hum Reprod; 2007 Sep; 22(9):2414-21. PubMed ID: 17636277
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
6. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations.
Lukaszuk K; Kunicki M; Liss J; Bednarowska A; Jakiel G
Reprod Biomed Online; 2014 Jan; 28(1):64-9. PubMed ID: 24268729
[TBL] [Abstract][Full Text] [Related]
7. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
8. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
9. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles.
Tal R; Seifer DB; Khanimov M; Schwartz E; Grazi RV; Malter HE
Reprod Biomed Online; 2013 Apr; 26(4):360-7. PubMed ID: 23419793
[TBL] [Abstract][Full Text] [Related]
11. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
12. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
[TBL] [Abstract][Full Text] [Related]
13. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.
Wang JG; Douglas NC; Nakhuda GS; Choi JM; Park SJ; Thornton MH; Guarnaccia MM; Sauer MV
Reprod Biomed Online; 2010 Dec; 21(6):757-61. PubMed ID: 21044868
[TBL] [Abstract][Full Text] [Related]
14. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
Abdalla H; Thum MY
Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
[TBL] [Abstract][Full Text] [Related]
15. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
[TBL] [Abstract][Full Text] [Related]
16. Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate.
Chen YP; Wu WH; Wu HM; Chen CK; Wang HS; Huang HY
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):313-6. PubMed ID: 25286783
[TBL] [Abstract][Full Text] [Related]
17. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
Fridén B; Sjöblom P; Menezes J
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118
[TBL] [Abstract][Full Text] [Related]
18. Cumulative live-birth rates after in vitro fertilization.
Malizia BA; Hacker MR; Penzias AS
N Engl J Med; 2009 Jan; 360(3):236-43. PubMed ID: 19144939
[TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction.
La Marca A; Nelson SM; Sighinolfi G; Manno M; Baraldi E; Roli L; Xella S; Marsella T; Tagliasacchi D; D'Amico R; Volpe A
Reprod Biomed Online; 2011 Apr; 22(4):341-9. PubMed ID: 21317041
[TBL] [Abstract][Full Text] [Related]
20. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest.
Alson SSE; Bungum LJ; Giwercman A; Henic E
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():199-204. PubMed ID: 29738982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
